- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Castration-resistant Prostate Cancer
Total 5635 results
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
-
Hoffmann-La RocheTerminatedCastration-Resistant Prostatic CancerSpain, France, Switzerland, Italy
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
DendreonNot yet recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
OncoC4, Inc.Prostate Cancer Clinical Trials ConsortiumRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerFrance, Lithuania, Israel, Italy, United Kingdom, Austria
-
FutureChemActive, not recruitingMetastatic Castration-resistant Prostate Cancer, mCRPCKorea, Republic of
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedMetastatic Castration Resistant Prostate Cancer (mCRPC)Italy
-
Centre Francois BaclesseGIRCI (French Interregional Group of Clinical Research and Innovation); Ligue...TerminatedMetastasis | Castration-resistant Prostate CancerFrance
-
SL VAXiGENRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)Korea, Republic of
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruitingMetastatic Castration-resistant Prostate Cancer, mCRPC
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
University of OklahomaDendreonRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Fudan UniversityRecruitingProstate Cancer | Castration-resistant Prostate Cancer | Metastatic DiseaseChina
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerChina
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
BayerNot yet recruitingNon-metastatic Castration-resistant Prostate Cancer | Metastatic Hormone-sensitive Prostate CancerKorea, Republic of
-
University of WashingtonNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterActive, not recruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer MetastaticUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer
-
Xencor, Inc.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States
-
BayerActive, not recruitingCastration-resistant Prostate CancerTaiwan
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
UNICANCERBayerNot yet recruitingProstatic Cancer, Castration-Resistant
-
National Cancer Institute (NCI)SuspendedCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
BayerRecruitingAdvanced Metastatic Castration-resistant Prostate Cancer | Prostate Specific Membrane Antigen (PSMA) ExpressionCanada, United Kingdom, Belgium
-
UNICANCERInstitut Bergonié; National Cancer Institute, France; Institut du Cancer de Montpellier...CompletedChemotherapy | Castration-resistant Prostate Cancer | Prostate Carcinoma | Circulating Tumor CellsFrance
-
Rana McKay, MDBristol-Myers Squibb; ExelixisRecruitingMetastatic Cancer | Castration-resistant Prostate CancerUnited States
-
University Hospital, Basel, SwitzerlandNot yet recruitingCastration-resistant Prostate CancerSwitzerland
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)France
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseRecruitingCastration Resistant Metastatic Prostate CancerUnited States
-
Noxopharm LimitedTerminatedMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnMicrosatellite Instability | Hormone-Resistant Prostate Cancer | Castration Levels of TestosteroneUnited States
-
Peking University Cancer Hospital & InstituteNot yet recruitingMetastatic Castration-resistant Prostate Cancer